Showing results (71-80 of 405) with videos related to

Sort By:
Pageof 41
Scientific Reports|July 26, 2020
Identification of TNFAIP3 as relapse biomarker and potential therapeutic target for MOG antibody associated diseasesShrishti Saxena, Hrishikesh Lokhande, Grace Gombolay, et al.
Journal of the Neurological Sciences|January 22, 2011
Accounting for disease modifying therapy in models of clinical progression in multiple sclerosisBrian C Healy, David Engler, Taha Gholipour, et al.
Neurology|August 31, 2016
Pediatric multiple sclerosis: Escalation and emerging treatmentsTanuja Chitnis, Angelo Ghezzi, Barbara Bajer-Kornek, et al.
Journal of the American Society of Nephrology : JASN|March 28, 2003
A novel mechanism for the immunomodulatory functions of class II MHC-derived peptidesBarbara Murphy, Joyce Yu, Qingsheng Jiao, et al.
Journal of Psychosomatic Research|September 24, 2020
Social support in multiple sclerosis: Associations with quality of life, depression, and anxietyAdrianna Ratajska, Bonnie I Glanz, Tanuja Chitnis, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|November 16, 2021
Patient-reported outcomes associated with transition to secondary progressive multiple sclerosisBrian C Healy, Jonathan Zurawski, Tanuja Chitnis, et al.
Multiple Sclerosis and Related Disorders|September 25, 2019
Adipokines are associated with pediatric multiple sclerosis risk and courseKiandokht Keyhanian, Shrishti Saxena, Grace Gombolay, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 3, 2012
Effect of gender on late-onset multiple sclerosisRiley M Bove, Brian Healy, Ann Augustine, et al.
Pageof 41